COPYRIGHT: A NEW FRONTIER IN DIABETES MANAGEMENT

The pharmaceutical industry has observed a remarkable advancement in diabetes management with the arrival of copyright. This transformative medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, offers a novel approach to regulating blood sugar levels in individuals with type 2 diabetes. copyright operates by simulating the a